BACE1 and Alzheimer disease: For instance, studies have shown that plasma levels of lncRNA BACE1 were significantly high in AD patients as compared to healthy controls and this increased plasma expression level lncRNA BACE1 levels is positively correlated with severity of cognitive deficits in AD patients [20,62].